L&C BIO Co.,LTD Statistics

Total Valuation

L&C BIO Co.,LTD has a market cap or net worth of KRW 488.86 billion. The enterprise value is 555.25 billion.

Market Cap	488.86B
Enterprise Value	555.25B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

L&C BIO Co.,LTD has 22.68 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	22.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	29.86%
Owned by Institutions (%)	15.05%
Float	15.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.98
PB Ratio	3.41
P/TBV Ratio	3.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.22, with an EV/FCF ratio of -13.22.

EV / Earnings	-93.15
EV / Sales	7.93
EV / EBITDA	60.22
EV / EBIT	228.96
EV / FCF	-13.22

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.54.

Current Ratio	1.11
Quick Ratio	0.51
Debt / Equity	0.54
Debt / EBITDA	8.98
Debt / FCF	-1.97
Interest Coverage	0.39

Financial Efficiency

Return on equity (ROE) is -3.64% and return on invested capital (ROIC) is 0.64%.

Return on Equity (ROE)	-3.64%
Return on Assets (ROA)	0.58%
Return on Capital (ROIC)	0.64%
Revenue Per Employee	538.70M
Profits Per Employee	-45.85M
Employee Count	130
Asset Turnover	0.27
Inventory Turnover	0.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.58%
50-Day Moving Average	18,179.00
200-Day Moving Average	20,143.90
Relative Strength Index (RSI)	66.77
Average Volume (20 Days)	131,384

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, L&C BIO Co.,LTD had revenue of KRW 70.03 billion and -5.96 billion in losses. Loss per share was -262.78.

Revenue	70.03B
Gross Profit	33.97B
Operating Income	2.43B
Pretax Income	-5.78B
Net Income	-5.96B
EBITDA	9.22B
EBIT	2.43B
Loss Per Share	-262.78

Full Income Statement

Balance Sheet

The company has 26.69 billion in cash and 82.84 billion in debt, giving a net cash position of -56.15 billion or -2,475.04 per share.

Cash & Cash Equivalents	26.69B
Total Debt	82.84B
Net Cash	-56.15B
Net Cash Per Share	-2,475.04
Equity (Book Value)	153.73B
Book Value Per Share	6,325.44
Working Capital	10.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.72 billion and capital expenditures -26.28 billion, giving a free cash flow of -41.99 billion.

Operating Cash Flow	-15.72B
Capital Expenditures	-26.28B
Free Cash Flow	-41.99B
FCF Per Share	-1,851.15

Full Cash Flow Statement

Margins

Gross margin is 48.50%, with operating and profit margins of 3.46% and -8.51%.

Gross Margin	48.50%
Operating Margin	3.46%
Pretax Margin	-8.26%
Profit Margin	-8.51%
EBITDA Margin	13.17%
EBIT Margin	3.46%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.46%.

Dividend Per Share	100.00
Dividend Yield	0.46%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.46%
Earnings Yield	-1.22%
FCF Yield	-8.59%

Dividend Details

Stock Splits

The last stock split was on October 12, 2020. It was a forward split with a ratio of 3.

Last Split Date	Oct 12, 2020
Split Type	Forward
Split Ratio	3

Scores

L&C BIO Co.,LTD has an Altman Z-Score of 4.16.

Altman Z-Score	4.16
Piotroski F-Score	n/a